Robert Ho - 01 Feb 2022 Form 4 Insider Report for Neoleukin Therapeutics, Inc. (NGNE)

Reporting relationship: Chief Financial Officer
Issuer ticker: NGNE
Reported as of: 01 Feb 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Feb 2022, 15:36:59 UTC
Prior SEC filing: 05 Aug 2021
Next SEC filing: 14 Sep 2022
Source filing: View source filing
Reporting owner signature: /s/ Robert Ho

Key filing fact

Robert Ho filed Form 4 for Neoleukin Therapeutics, Inc. (NGNE) on 02 Feb 2022.

Key facts

This page summarizes Robert Ho's Form 4 filing for Neoleukin Therapeutics, Inc. (NGNE).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Feb 2022, 15:36.

Change

Previous filing in this sequence was filed on 05 Aug 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NLTX transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +70,000
Change %
Price: $0.000000
Shares after: 70,000
Date: 01 Feb 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 70,000
Exercise price: $0.000000
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration.

Footnote F2

The RSUs will vest as to 1/2 of the total number of shares underlying the award on each of February 1, 2023 and February 1, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Footnote F3

The RSUs do not expire; these securities either vest and settle or are canceled prior to the vesting date.

SEC remarks

Exhibit 24.1 - Power of Attorney